| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Co-Repressor 2 | 16 | 2022 | 26 | 2.430 |
Why?
|
| Laminin | 5 | 2022 | 89 | 2.120 |
Why?
|
| Adipocytes | 12 | 2022 | 180 | 1.830 |
Why?
|
| Energy Metabolism | 6 | 2021 | 314 | 1.720 |
Why?
|
| Adipose Tissue | 9 | 2021 | 280 | 1.520 |
Why?
|
| PPAR gamma | 7 | 2022 | 80 | 1.270 |
Why?
|
| Repressor Proteins | 11 | 2009 | 449 | 1.110 |
Why?
|
| Receptors, Thyroid Hormone | 12 | 2015 | 158 | 1.000 |
Why?
|
| Cell Differentiation | 9 | 2024 | 1647 | 0.950 |
Why?
|
| Obesity | 5 | 2021 | 1077 | 0.890 |
Why?
|
| Nuclear Proteins | 10 | 2015 | 755 | 0.720 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 73 | 0.710 |
Why?
|
| DNA-Binding Proteins | 8 | 2009 | 1268 | 0.700 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1116 | 0.650 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 147 | 0.650 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 61 | 0.630 |
Why?
|
| Insulin Resistance | 3 | 2022 | 391 | 0.610 |
Why?
|
| Thyroid Neoplasms | 3 | 2025 | 469 | 0.590 |
Why?
|
| Thyroid Diseases | 2 | 2019 | 108 | 0.570 |
Why?
|
| Subcutaneous Fat | 2 | 2018 | 23 | 0.560 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2022 | 24 | 0.560 |
Why?
|
| Mice | 32 | 2024 | 12735 | 0.560 |
Why?
|
| Adiposity | 2 | 2018 | 81 | 0.550 |
Why?
|
| Adipose Tissue, Beige | 1 | 2018 | 3 | 0.540 |
Why?
|
| Thyroid Hormones | 8 | 2019 | 358 | 0.540 |
Why?
|
| Thyroxine | 3 | 2019 | 411 | 0.520 |
Why?
|
| Thermogenesis | 3 | 2022 | 49 | 0.520 |
Why?
|
| Adipose Tissue, Brown | 4 | 2022 | 98 | 0.510 |
Why?
|
| Animals | 39 | 2024 | 28981 | 0.490 |
Why?
|
| Macrophages | 1 | 2020 | 643 | 0.490 |
Why?
|
| Uncoupling Protein 1 | 4 | 2022 | 45 | 0.480 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 65 | 0.470 |
Why?
|
| Adipose Tissue, White | 5 | 2022 | 30 | 0.470 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 369 | 0.470 |
Why?
|
| Dexamethasone | 2 | 2015 | 318 | 0.450 |
Why?
|
| Organ Specificity | 3 | 2021 | 287 | 0.430 |
Why?
|
| Hypopituitarism | 2 | 2005 | 17 | 0.430 |
Why?
|
| Mice, Knockout | 9 | 2022 | 2212 | 0.430 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 481 | 0.410 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 145 | 0.390 |
Why?
|
| Adipocytes, White | 2 | 2024 | 6 | 0.390 |
Why?
|
| Gene Silencing | 2 | 2010 | 178 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 3616 | 0.330 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2014 | 127 | 0.320 |
Why?
|
| Receptors, Retinoic Acid | 4 | 2022 | 48 | 0.310 |
Why?
|
| Histone Deacetylases | 3 | 2022 | 85 | 0.310 |
Why?
|
| Leptin | 1 | 2010 | 102 | 0.300 |
Why?
|
| Basement Membrane | 2 | 2021 | 58 | 0.290 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2858 | 0.290 |
Why?
|
| Weight Gain | 4 | 2019 | 138 | 0.290 |
Why?
|
| Insulin | 2 | 2010 | 1224 | 0.260 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 13 | 0.260 |
Why?
|
| Response Elements | 5 | 2007 | 68 | 0.260 |
Why?
|
| Cardiac Output | 1 | 2007 | 142 | 0.250 |
Why?
|
| Hypoxia, Brain | 1 | 2007 | 41 | 0.250 |
Why?
|
| Adipogenesis | 2 | 2024 | 46 | 0.250 |
Why?
|
| Dimerization | 8 | 2007 | 149 | 0.240 |
Why?
|
| Male | 19 | 2025 | 47263 | 0.240 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2005 | 5 | 0.230 |
Why?
|
| Pituitary Hormones | 1 | 2005 | 7 | 0.230 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2006 | 81 | 0.230 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2005 | 28 | 0.230 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 241 | 0.230 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 5 | 2006 | 117 | 0.220 |
Why?
|
| Transcriptional Activation | 4 | 2007 | 293 | 0.220 |
Why?
|
| Transfection | 7 | 2009 | 883 | 0.220 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1133 | 0.210 |
Why?
|
| Adipocytes, Beige | 1 | 2024 | 5 | 0.210 |
Why?
|
| Microscopy, Atomic Force | 1 | 2024 | 54 | 0.210 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2022 | 24 | 0.210 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2025 | 169 | 0.200 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2003 | 6 | 0.200 |
Why?
|
| Cell Adhesion | 2 | 2024 | 420 | 0.200 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 540 | 0.200 |
Why?
|
| Humans | 30 | 2025 | 98370 | 0.190 |
Why?
|
| PPAR delta | 1 | 2022 | 3 | 0.190 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2022 | 18 | 0.190 |
Why?
|
| Thyrotropin | 3 | 2019 | 328 | 0.190 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2022 | 57 | 0.180 |
Why?
|
| Protein Binding | 8 | 2007 | 1561 | 0.180 |
Why?
|
| Luciferases | 3 | 2015 | 128 | 0.180 |
Why?
|
| 3T3-L1 Cells | 3 | 2007 | 37 | 0.180 |
Why?
|
| Retinoid X Receptors | 4 | 2007 | 38 | 0.180 |
Why?
|
| Adipocytes, Brown | 1 | 2022 | 12 | 0.180 |
Why?
|
| Diet, High-Fat | 3 | 2018 | 144 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 301 | 0.170 |
Why?
|
| Genes, Reporter | 3 | 2015 | 277 | 0.170 |
Why?
|
| Glutathione Transferase | 5 | 2009 | 116 | 0.170 |
Why?
|
| Tissue Array Analysis | 1 | 2022 | 135 | 0.170 |
Why?
|
| Receptor Cross-Talk | 2 | 2015 | 32 | 0.170 |
Why?
|
| Body Weight | 3 | 2019 | 456 | 0.160 |
Why?
|
| Integrins | 1 | 2021 | 83 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 565 | 0.160 |
Why?
|
| Liver | 3 | 2022 | 1230 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2021 | 3633 | 0.160 |
Why?
|
| Fibroblasts | 3 | 2015 | 766 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 114 | 0.160 |
Why?
|
| Gene Expression | 3 | 2019 | 1322 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2016 | 615 | 0.160 |
Why?
|
| Hypothyroidism | 3 | 2013 | 299 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 6 | 2007 | 733 | 0.150 |
Why?
|
| Transcription Factors | 7 | 2015 | 1721 | 0.150 |
Why?
|
| Epidermis | 1 | 2020 | 106 | 0.150 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 568 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 260 | 0.150 |
Why?
|
| Adenosine | 1 | 2022 | 291 | 0.150 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 2023 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2009 | 273 | 0.140 |
Why?
|
| Triglycerides | 3 | 2019 | 234 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2021 | 743 | 0.140 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 201 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 310 | 0.140 |
Why?
|
| Protein Isoforms | 4 | 2007 | 304 | 0.140 |
Why?
|
| Phenotype | 3 | 2020 | 2667 | 0.140 |
Why?
|
| Reference Values | 1 | 2019 | 608 | 0.140 |
Why?
|
| Lipolysis | 2 | 2015 | 24 | 0.140 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 120 | 0.140 |
Why?
|
| Homeostasis | 1 | 2020 | 474 | 0.130 |
Why?
|
| Postpartum Period | 1 | 2019 | 169 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2007 | 1396 | 0.130 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 31 | 0.130 |
Why?
|
| Microfluidics | 1 | 2018 | 60 | 0.130 |
Why?
|
| Female | 16 | 2025 | 51761 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2018 | 162 | 0.130 |
Why?
|
| Energy Intake | 1 | 2018 | 100 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 670 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2005 | 557 | 0.130 |
Why?
|
| Cell Line | 7 | 2006 | 2483 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 295 | 0.130 |
Why?
|
| Thiazolidinediones | 2 | 2009 | 76 | 0.120 |
Why?
|
| Mutant Proteins | 2 | 2007 | 99 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 478 | 0.120 |
Why?
|
| Mutation | 8 | 2025 | 4428 | 0.120 |
Why?
|
| Thymocytes | 1 | 2016 | 33 | 0.120 |
Why?
|
| Executive Function | 1 | 2017 | 115 | 0.120 |
Why?
|
| Young Adult | 4 | 2025 | 7568 | 0.120 |
Why?
|
| Pregnancy | 3 | 2019 | 3269 | 0.120 |
Why?
|
| Adult | 8 | 2025 | 29587 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 119 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2017 | 160 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2018 | 257 | 0.110 |
Why?
|
| Point Mutation | 3 | 2005 | 237 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 980 | 0.110 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2017 | 239 | 0.110 |
Why?
|
| Epididymis | 1 | 2015 | 19 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2577 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2006 | 2008 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 84 | 0.110 |
Why?
|
| Memory | 1 | 2017 | 234 | 0.110 |
Why?
|
| Binding Sites | 6 | 2006 | 1160 | 0.110 |
Why?
|
| Chorionic Gonadotropin | 1 | 2014 | 69 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2010 | 1607 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 2897 | 0.100 |
Why?
|
| Ligands | 6 | 2007 | 491 | 0.100 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 44 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1568 | 0.100 |
Why?
|
| Endocrine System | 1 | 2013 | 16 | 0.100 |
Why?
|
| Protein Transport | 1 | 2015 | 447 | 0.100 |
Why?
|
| Growth Hormone | 1 | 2013 | 96 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2025 | 1539 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 166 | 0.100 |
Why?
|
| Thyroid Dysgenesis | 1 | 2013 | 10 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2013 | 50 | 0.090 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 74 | 0.090 |
Why?
|
| Middle Aged | 6 | 2025 | 29532 | 0.090 |
Why?
|
| Attention | 1 | 2017 | 435 | 0.090 |
Why?
|
| Congenital Hypothyroidism | 1 | 2013 | 86 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2016 | 710 | 0.090 |
Why?
|
| AIDS Dementia Complex | 1 | 2011 | 7 | 0.090 |
Why?
|
| HIV | 1 | 2011 | 48 | 0.080 |
Why?
|
| Plasmids | 2 | 2009 | 275 | 0.080 |
Why?
|
| Corpus Callosum | 1 | 2011 | 58 | 0.080 |
Why?
|
| Prevalence | 3 | 2025 | 1393 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 73 | 0.080 |
Why?
|
| Pituitary Gland | 2 | 2013 | 117 | 0.080 |
Why?
|
| Biomarkers | 2 | 2014 | 2021 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 7 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2010 | 21 | 0.080 |
Why?
|
| Serpins | 1 | 2010 | 31 | 0.080 |
Why?
|
| Glycogen | 1 | 2010 | 58 | 0.080 |
Why?
|
| Neuroimaging | 1 | 2011 | 143 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2010 | 54 | 0.080 |
Why?
|
| Base Sequence | 4 | 2006 | 2224 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 147 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 74 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2010 | 131 | 0.070 |
Why?
|
| 3T3 Cells | 1 | 2009 | 94 | 0.070 |
Why?
|
| Consensus Sequence | 3 | 2006 | 63 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2019 | 779 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 212 | 0.070 |
Why?
|
| Heterozygote | 1 | 2010 | 392 | 0.070 |
Why?
|
| Lipogenesis | 2 | 2022 | 29 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 211 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 582 | 0.070 |
Why?
|
| DNA Primers | 1 | 2009 | 530 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 281 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 335 | 0.070 |
Why?
|
| Renin | 1 | 2007 | 67 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3612 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1290 | 0.060 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2006 | 18 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 34 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2010 | 502 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 137 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2007 | 277 | 0.060 |
Why?
|
| Calcitriol | 1 | 2007 | 173 | 0.060 |
Why?
|
| Thyroid Gland | 3 | 2005 | 297 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 100 | 0.060 |
Why?
|
| Heart Failure | 1 | 2017 | 1502 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2006 | 50 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 3285 | 0.060 |
Why?
|
| DNA | 4 | 2007 | 1275 | 0.060 |
Why?
|
| Lipids | 2 | 2019 | 295 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 2688 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2017 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2005 | 161 | 0.050 |
Why?
|
| Elasticity | 1 | 2024 | 98 | 0.050 |
Why?
|
| Prognosis | 2 | 2014 | 4126 | 0.050 |
Why?
|
| Transcription Factor HES-1 | 1 | 2003 | 7 | 0.050 |
Why?
|
| RNA Interference | 1 | 2005 | 388 | 0.050 |
Why?
|
| Models, Biological | 3 | 2018 | 1805 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2022 | 57 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 931 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1974 | 0.050 |
Why?
|
| Cholesterol | 2 | 2019 | 376 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 36 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 416 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2022 | 48 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 1018 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 234 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21844 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 2056 | 0.040 |
Why?
|
| Risk Factors | 2 | 2013 | 6273 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 527 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 994 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2001 | 148 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2016 | 424 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 427 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 39 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2020 | 49 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 87 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 220 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2006 | 24 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 118 | 0.040 |
Why?
|
| Histone Acetyltransferases | 3 | 2006 | 45 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 147 | 0.040 |
Why?
|
| Echocardiography | 2 | 2019 | 784 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 355 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 239 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 523 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1998 | 47 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 704 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2001 | 572 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 4818 | 0.030 |
Why?
|
| Glycerol | 1 | 2018 | 35 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 403 | 0.030 |
Why?
|
| Neurons | 1 | 2006 | 1626 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 208 | 0.030 |
Why?
|
| Pedigree | 2 | 2013 | 987 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2000 | 447 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 253 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2016 | 8 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 17 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 22 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 27 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 7418 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 101 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 139 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 71 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 2085 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 388 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1142 | 0.020 |
Why?
|
| Abortion, Habitual | 1 | 2013 | 31 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2013 | 2551 | 0.020 |
Why?
|
| Live Birth | 1 | 2013 | 23 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 48 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2016 | 386 | 0.020 |
Why?
|
| PAX8 Transcription Factor | 1 | 2013 | 27 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 342 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 104 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 453 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 221 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 352 | 0.020 |
Why?
|
| Child | 3 | 2013 | 7750 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2011 | 75 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 408 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 5 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2010 | 13 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 162 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2010 | 67 | 0.020 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2010 | 12 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1570 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 85 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 11043 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2011 | 288 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 426 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2010 | 95 | 0.020 |
Why?
|
| Fasting | 1 | 2010 | 166 | 0.020 |
Why?
|
| Triiodothyronine | 2 | 2003 | 367 | 0.020 |
Why?
|
| Aging | 1 | 2014 | 770 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 679 | 0.020 |
Why?
|
| Chicago | 1 | 2013 | 1519 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 889 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 830 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 506 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1145 | 0.020 |
Why?
|
| Otx Transcription Factors | 1 | 2006 | 4 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1296 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 1986 | 38 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 2009 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 173 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 3228 | 0.010 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1986 | 69 | 0.010 |
Why?
|
| Cognition | 1 | 2011 | 669 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2005 | 3 | 0.010 |
Why?
|
| Liver X Receptors | 1 | 2005 | 22 | 0.010 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2005 | 20 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 596 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 218 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2005 | 72 | 0.010 |
Why?
|
| Ovary | 1 | 2006 | 262 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 4042 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 83 | 0.010 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2004 | 4 | 0.010 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2004 | 8 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1986 | 243 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 163 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 157 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 195 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1986 | 261 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 2003 | 27 | 0.010 |
Why?
|
| Chromatin | 1 | 2007 | 461 | 0.010 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 221 | 0.010 |
Why?
|
| Genes, erbA | 1 | 2003 | 11 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1752 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 281 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 348 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 213 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 118 | 0.010 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2002 | 14 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 435 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 1006 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 424 | 0.010 |
Why?
|
| Cerebellar Diseases | 1 | 2001 | 23 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 442 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 2001 | 69 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2001 | 82 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 446 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2070 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 554 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2003 | 402 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 1163 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 746 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 9770 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2002 | 284 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 1334 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1817 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 238 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1998 | 43 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2896 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 826 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2439 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 5577 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 100 | 0.000 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 98 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 187 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 822 | 0.000 |
Why?
|